Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1635099

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1635099

Cardiac Monitoring Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)

PUBLISHED:
PAGES: 320 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The global cardiac monitoring market is projected to grow from an estimated $27.1 billion in 2024 to $36.1 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.9% during the forecast period. This growth is driven by the rising prevalence of cardiovascular diseases (CVDs), which are the leading cause of death worldwide, accounting for approximately 17.9 million deaths annually. Factors such as high tobacco use, elevated cholesterol levels, obesity, physical inactivity, diabetes, poor diet, and alcohol consumption contribute significantly to heart health issues, necessitating continuous cardiac monitoring.

Key Insights

The introduction of innovative cardiac monitoring devices, such as wearable technologies with ECG capabilities, has enhanced early detection and management of arrhythmias like atrial fibrillation. Modern smartwatches equipped with ECG apps can detect irregular heart rhythms, facilitating timely medical intervention.

Mobile cardiac telemetry (MCT) systems represent a significant advancement in cardiac monitoring, offering real-time, continuous observation of cardiac activity. The demand for MCT is expected to grow substantially during the forecast period, driven by the increasing incidence of cardiac diseases and the need for efficient remote monitoring solutions.

The economic burden of heart diseases is substantial, emphasizing the need for effective cardiac monitoring solutions. Early detection and management of CVDs through advanced monitoring can potentially reduce healthcare costs and improve patient outcomes.

The rising adoption of digital health services is intensifying market growth. Major acquisitions in the healthcare sector are integrating in-office and virtual care, on-site labs, and comprehensive health programs, enhancing the accessibility and efficiency of cardiac monitoring services.

North America holds the largest market share, attributed to the high prevalence of CVDs, advanced healthcare infrastructure, and early adoption of innovative technologies. The Asia-Pacific region is anticipated to experience the fastest growth, propelled by increasing healthcare investments, rising awareness of heart health, and a growing aging population susceptible to heart diseases.

Despite the advancements, challenges such as the high cost of advanced cardiac monitoring devices, regulatory hurdles, and concerns regarding data privacy and security may hinder market growth. However, ongoing technological innovations and supportive government initiatives are expected to mitigate these challenges over time.

Product Code: 12317

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by mode
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2019-2030)
  • 6.3. Market Revenue, by Mode (2019-2030)
  • 6.4. Market Revenue, by End User (2019-2030)
  • 6.5. Market Revenue, by Region (2019-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2019-2030)
  • 7.3. Market Revenue, by Mode (2019-2030)
  • 7.4. Market Revenue, by End User (2019-2030
  • 7.5. Market Revenue, by Country (2019-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2019-2030)
  • 8.3. Market Revenue, by Mode (2019-2030)
  • 8.4. Market Revenue, by End User (2019-2030
  • 8.5. Market Revenue, by Country (2019-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2019-2030)
  • 9.3. Market Revenue, by Mode (2019-2030)
  • 9.4. Market Revenue, by End User (2019-2030
  • 9.5. Market Revenue, by Country (2019-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2019-2030)
  • 10.3. Market Revenue, by Mode (2019-2030)
  • 10.4. Market Revenue, by End User (2019-2030
  • 10.5. Market Revenue, by Country (2019-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2019-2030)
  • 11.3. Market Revenue, by Mode (2019-2030)
  • 11.4. Market Revenue, by End User (2019-2030
  • 11.5. Market Revenue, by Country (2019-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2019-2030)
  • 12.3. Market Revenue, by Mode (2019-2030)
  • 12.4. Market Revenue, by End User (2019-2030

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2019-2030)
  • 13.3. Market Revenue, by Mode (2019-2030)
  • 13.4. Market Revenue, by End User (2019-2030

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2019-2030)
  • 14.3. Market Revenue, by Mode (2019-2030)
  • 14.4. Market Revenue, by End User (2019-2030

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2019-2030)
  • 15.3. Market Revenue, by Mode (2019-2030)
  • 15.4. Market Revenue, by End User (2019-2030

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2019-2030)
  • 16.3. Market Revenue, by Mode (2019-2030)
  • 16.4. Market Revenue, by End User (2019-2030

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2019-2030)
  • 17.3. Market Revenue, by Mode (2019-2030)
  • 17.4. Market Revenue, by End User (2019-2030

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2019-2030)
  • 18.3. Market Revenue, by Mode (2019-2030)
  • 18.4. Market Revenue, by End User (2019-2030

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2019-2030)
  • 19.3. Market Revenue, by Mode (2019-2030)
  • 19.4. Market Revenue, by End User (2019-2030

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2019-2030)
  • 20.3. Market Revenue, by Mode (2019-2030)
  • 20.4. Market Revenue, by End User (2019-2030

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2019-2030)
  • 21.3. Market Revenue, by Mode (2019-2030)
  • 21.4. Market Revenue, by End User (2019-2030

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2019-2030)
  • 22.3. Market Revenue, by Mode (2019-2030)
  • 22.4. Market Revenue, by End User (2019-2030

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2019-2030)
  • 23.3. Market Revenue, by Mode (2019-2030)
  • 23.4. Market Revenue, by End User (2019-2030

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2019-2030)
  • 24.3. Market Revenue, by Mode (2019-2030)
  • 24.4. Market Revenue, by End User (2019-2030

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2019-2030)
  • 25.3. Market Revenue, by Mode (2019-2030)
  • 25.4. Market Revenue, by End User (2019-2030

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2019-2030)
  • 26.3. Market Revenue, by Mode (2019-2030)
  • 26.4. Market Revenue, by End User (2019-2030

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2019-2030)
  • 27.3. Market Revenue, by Mode (2019-2030)
  • 27.4. Market Revenue, by End User (2019-2030

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2019-2030)
  • 28.3. Market Revenue, by Mode (2019-2030)
  • 28.4. Market Revenue, by End User (2019-2030

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Medtronic plc
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Boston Scientific Corporation
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Abbott Laboratories
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. GE HealthCare
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. BIOTRONIK
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Koninklijke Philips N.V.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Asahi Kasei Corporation
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. MicroPort Scientific Corporation
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Hill-Rom Holdings Inc.
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Nihon Kohden Corporation
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary
  • 30.11. Nasiff Associates Inc.
    • 30.11.1. Business overview
    • 30.11.2. Product and service offerings
    • 30.11.3. Key financial summary
  • 30.12. iRhythm Technologies Inc.
    • 30.12.1. Business overview
    • 30.12.2. Product and service offerings
    • 30.12.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!